More from this Publisher
More from this Publisher
Related Documents
-
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Anti-Infective Drugs Advisory Committee et al.
28 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— TEQUIN injection, 10 milligrams
67 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
22 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Arthritis Advisory Committee
56 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PHENERGAN (Promethazine hydrochloride) tablets, 12.5 milligrams and 50 milligrams
88 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
15 reads -
Notice: Grant and cooperative agreement awards: Society for Advancement of Violence and Injury Research
10 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Animal Drug User Fee Act; performance and reauthorization
37 reads -
Notice: Human drugs:
New drug applications— Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent; approval withdrawn
98 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— DECADRON tablets
114 reads -
Notice: Human drugs:
New drug applications— High Chemical Co., et al. approval withdrawn
34 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— SURPASS
48 reads -
Notice: Human drugs:
Best Pharmaceuticals for Children Act— ALOXI
61 reads -
Notice: Privacy Act; computer matching programs
16 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
62 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
34 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
73 reads -
Notice: Human drugs:
Patent extension; regulatory review period determinations— TARCEVA
38 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— PEPTAVLON (Pentagastrin) for subcutaneous injection, 0.25 milligrams per milliliter
144 reads -
Notice: Human drugs:
New drug applications— INSPRA
195 reads
Related Documents
Flag this document
1 Page
